Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...

Millions remain unscreened for colorectal cancer. Learn how noninvasive screening can expand access, preserve capacity, and ...

According to a 2025 survey conducted by the Prevent Cancer Foundation, only 51% of U.S. adults 21 and older say they have had ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

Two new studies report worse colorectal cancer survival among patients with lower socioeconomic status, adding weight to a ...

Blood wey dey show for poo-poo no be always sign say na colon cancer. We tell you wetin be di oda problems wey fit cause ...

Guardant Health's Shield blood test for colorectal cancer screening is now covered by TRICARE, providing active duty service ...

Active-duty service members and eligible family members in Alaska now have access to blood test for colorectal cancer screening with no copay.

Colonoscopy remains a cornerstone of colorectal cancer prevention, but GI leaders say the procedure’s role, and the business model built around it, is shifting fast. Here’s what five leaders have told ...

Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, ...

By Cheryl Harewood Barbados has one of the highest incidences of colorectal cancer globally and according to the Pan American ...